Cargando…
Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer
Sialyltransferases transfer sialic acid to nascent oligosaccharides and are upregulated in cancer. The inhibition of sialyltransferases is emerging as a potential strategy to prevent metastasis in several cancers, including ovarian cancer. ST3GAL1 is a sialyltransferase that catalyzes the transfer o...
Autores principales: | Wu, Xin, Zhao, Junda, Ruan, Yuanyuan, Sun, Li, Xu, Congjian, Jiang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207573/ https://www.ncbi.nlm.nih.gov/pubmed/30375371 http://dx.doi.org/10.1038/s41419-018-1101-0 |
Ejemplares similares
-
ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells
por: Schultz, Matthew J, et al.
Publicado: (2013) -
Expression of Functional Human Sialyltransferases ST3Gal1 and ST6Gal1 in Escherichia coli
por: Ortiz-Soto, Maria Elena, et al.
Publicado: (2016) -
Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness
por: Hait, Nitai C., et al.
Publicado: (2022) -
Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer
por: Smithson, Mary, et al.
Publicado: (2022) -
Regulation of inflammatory signaling by the ST6Gal-I sialyltransferase
por: Holdbrooks, Andrew T., et al.
Publicado: (2020)